Transcriptional and DNA Methylation Signatures of Subcutaneous Adipose Tissue and Adipose-Derived Stem Cells in PCOS Women

Cells

Edina Erdos¹  Timothy F. Osborne¹  Adeline Divoux²  Katie Whytock²  Steven R. Smith² 

[1] Departments of Medicine and Biological Chemistry, Division of Diabetes Endocrinology and Metabolism, Institute for Fundamental Biomedical Research, Pediatrics Johns Hopkins University School of Medicine, Johns Hopkins All Children’s Hospital, St. Petersburg, FL 33701, USA;Translational Research Institute, AdventHealth, Orlando, FL 32804, USA;

关键词: PCOS;    adipose tissue;    gluteofemoral;    adipose-derived stem cell;    transcriptome;    DNA methylation;   

DOI  :  10.3390/cells11050848

来源: DOAJ

【 摘 要 】

Polycystic ovary syndrome (PCOS) is often associated with metabolic syndrome features, including central obesity, suggesting that adipose tissue (AT) is a key organ in PCOS pathobiology. In this study, we compared both abdominal (ABD) and gluteofemoral (GF) subcutaneous AT in women with and without PCOS. ABD and GF subcutaneous ATs from PCOS and BMI/WHR-matched control women were analyzed by RT-qPCR, FACS and histology. ABD and GF adipose-derived stem cell (ASC) transcriptome and methylome were analyzed by RNA-seq and DNA methylation array. Similar to the control group with abdominal obesity, the GF AT of PCOS women showed lower expression of genes involved in lipid accumulation and angiogenesis compared to ABD depot. FACS analysis revealed an increase in preadipocytes number in both AT depots from PCOS. Further pathway analysis of RNA-seq comparisons demonstrated that the ASCs derived from PCOS are pro-inflammatory and exhibit a hypoxic signature in the ABD depot and have lower expression of adipogenic genes in GF depot. We also found a higher CpG methylation level in PCOS compared to control exclusively in GF-ASCs. Our data suggest that ASCs play an important role in the etiology of PCOS, potentially by limiting expansion of the healthy lower-body AT.

【 授权许可】

Unknown